Record #44378
Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
Journal
Publisher
Original paper date
Mar 27, 2019
Original DOI
Country
Institution
Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, China · Department of Emergency Medicine, the Second Affiliated Hospital, Southeast University, Nanjing, 210002, China · Department of Respiratory Medicine, the First People’s Hospital of Nantong, Nantong, 226000, China
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
32
Same day
0
Post-retraction
2
% post-retraction
5.9%
~7.8 citations/yr before retraction · ~0.6 citations/yr after
— citing papers
Who is still citing this work
Loading…